++
For further information, see CMDT Part 22-15: Minimal Change Disease
++
++
++
++
Prednisone, 60 mg/m2/day orally
Cyclophosphamide, a calcineurin inhibitor, or rituximab for patients with corticosteroid resistance or relapses
Progression to end-stage renal disease is rare
Complications most often related to prolonged corticosteroid use